CSS
VRDN icon

Cubist Systematic Strategies’s Viridian Therapeutics VRDN Stock Holding History

Cubist Systematic Strategies’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-50,898
Closed -$1.16M – 3615
2024
Q3 		$1.16M Buy
+50,898
New +$832K 0.01% 1738
2024
Q2 		– Sell
-69,430
Closed -$1.22M – 4095
2024
Q1 		$1.22M Buy
+69,430
New +$1.35M 0.01% 2012
2020
Q1 		– Sell
-67
Closed – – 2483
2019
Q4 		$0 Hold
67
– – ﹤0.01% 2562
2019
Q3 		$1K Sell
67
-66
-50% -$1.46K ﹤0.01% 2179
2019
Q2 		$4K Hold
133
– – ﹤0.01% 2418
2019
Q1 		$6K Sell
133
-34
-20% -$1.54K ﹤0.01% 2202
2018
Q4 		$8K Sell
167
-38
-19% -$2.2K ﹤0.01% 1990
2018
Q3 		$17K Buy
+205
New +$19.3K ﹤0.01% 1798

Other funds holding VRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return